nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—HDAC2—melanoma	0.525	0.897	CbGaD
Lovastatin—ABCB1—melanoma	0.06	0.102	CbGaD
Lovastatin—CYP3A4—Temozolomide—melanoma	0.03	0.16	CbGbCtD
Lovastatin—ABCC2—Docetaxel—melanoma	0.0289	0.154	CbGbCtD
Lovastatin—CYP2D6—Vemurafenib—melanoma	0.0259	0.138	CbGbCtD
Lovastatin—CYP3A7—Docetaxel—melanoma	0.0193	0.103	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0193	0.103	CbGbCtD
Lovastatin—ABCB1—Dactinomycin—melanoma	0.0183	0.0973	CbGbCtD
Lovastatin—CYP3A4—Vemurafenib—melanoma	0.0165	0.0877	CbGbCtD
Lovastatin—CYP3A5—Docetaxel—melanoma	0.0145	0.0772	CbGbCtD
Lovastatin—ABCB1—Docetaxel—melanoma	0.00943	0.0502	CbGbCtD
Lovastatin—CYP3A4—Docetaxel—melanoma	0.00565	0.0301	CbGbCtD
Lovastatin—ITGAL—endothelium—melanoma	0.00319	0.174	CbGeAlD
Lovastatin—ITGAL—blood vessel—melanoma	0.00294	0.161	CbGeAlD
Lovastatin—HDAC2—hair follicle—melanoma	0.00125	0.0686	CbGeAlD
Lovastatin—ITGAL—mammalian vulva—melanoma	0.00124	0.0679	CbGeAlD
Lovastatin—PON3—mammalian vulva—melanoma	0.00122	0.0666	CbGeAlD
Lovastatin—Lupus erythematosus—Docetaxel—melanoma	0.00116	0.0142	CcSEcCtD
Lovastatin—HMGCR—hair follicle—melanoma	0.00113	0.0619	CbGeAlD
Lovastatin—Transaminases increased—Carmustine—melanoma	0.0011	0.0135	CcSEcCtD
Lovastatin—Photosensitivity—Vemurafenib—melanoma	0.00105	0.0128	CcSEcCtD
Lovastatin—Arthritis—Vemurafenib—melanoma	0.000947	0.0116	CcSEcCtD
Lovastatin—Myopathy—Temozolomide—melanoma	0.000924	0.0113	CcSEcCtD
Lovastatin—Pain in extremity—Vemurafenib—melanoma	0.00092	0.0113	CcSEcCtD
Lovastatin—Tenderness—Bleomycin—melanoma	0.00088	0.0108	CcSEcCtD
Lovastatin—HDAC2—neck—melanoma	0.000841	0.046	CbGeAlD
Lovastatin—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.000829	0.0101	CcSEcCtD
Lovastatin—Memory impairment—Temozolomide—melanoma	0.000825	0.0101	CcSEcCtD
Lovastatin—Eosinophilia—Vemurafenib—melanoma	0.000787	0.00964	CcSEcCtD
Lovastatin—Systemic lupus erythematosus—Docetaxel—melanoma	0.000778	0.00953	CcSEcCtD
Lovastatin—HMGCR—neck—melanoma	0.000759	0.0415	CbGeAlD
Lovastatin—Accidental injury—Carmustine—melanoma	0.000758	0.00927	CcSEcCtD
Lovastatin—Photosensitivity reaction—Vemurafenib—melanoma	0.000726	0.00889	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.000703	0.00861	CcSEcCtD
Lovastatin—Neuropathy peripheral—Vemurafenib—melanoma	0.000695	0.00851	CcSEcCtD
Lovastatin—Musculoskeletal pain—Temozolomide—melanoma	0.000656	0.00803	CcSEcCtD
Lovastatin—Phosphatase alkaline increased—Temozolomide—melanoma	0.000648	0.00793	CcSEcCtD
Lovastatin—HDAC2—eye—melanoma	0.000626	0.0342	CbGeAlD
Lovastatin—ITGAL—lymph node—melanoma	0.000622	0.034	CbGeAlD
Lovastatin—HDAC2—retina—melanoma	0.00062	0.0339	CbGeAlD
Lovastatin—Injury—Bleomycin—melanoma	0.000607	0.00742	CcSEcCtD
Lovastatin—Erythema multiforme—Vemurafenib—melanoma	0.000602	0.00737	CcSEcCtD
Lovastatin—Gynaecomastia—Carmustine—melanoma	0.0006	0.00734	CcSEcCtD
Lovastatin—Hepatic failure—Dactinomycin—melanoma	0.000579	0.00708	CcSEcCtD
Lovastatin—Arthritis—Bleomycin—melanoma	0.000574	0.00702	CcSEcCtD
Lovastatin—Chills—Vemurafenib—melanoma	0.000571	0.00699	CcSEcCtD
Lovastatin—Alopecia—Vemurafenib—melanoma	0.000563	0.00689	CcSEcCtD
Lovastatin—HDAC2—skin of body—melanoma	0.000544	0.0298	CbGeAlD
Lovastatin—Dysgeusia—Vemurafenib—melanoma	0.000543	0.00664	CcSEcCtD
Lovastatin—Blood alkaline phosphatase increased—Temozolomide—melanoma	0.000541	0.00662	CcSEcCtD
Lovastatin—Back pain—Vemurafenib—melanoma	0.000536	0.00656	CcSEcCtD
Lovastatin—Injury—Carmustine—melanoma	0.000529	0.00648	CcSEcCtD
Lovastatin—Vascular purpura—Temozolomide—melanoma	0.000526	0.00644	CcSEcCtD
Lovastatin—Hepatic failure—Temozolomide—melanoma	0.000523	0.00641	CcSEcCtD
Lovastatin—Amnesia—Carmustine—melanoma	0.000518	0.00634	CcSEcCtD
Lovastatin—Eye irritation—Docetaxel—melanoma	0.000505	0.00618	CcSEcCtD
Lovastatin—Amnesia—Temozolomide—melanoma	0.000501	0.00613	CcSEcCtD
Lovastatin—HMGCR—skin of body—melanoma	0.000491	0.0269	CbGeAlD
Lovastatin—Purpura—Temozolomide—melanoma	0.000488	0.00597	CcSEcCtD
Lovastatin—Arthralgia—Vemurafenib—melanoma	0.000472	0.00577	CcSEcCtD
Lovastatin—Myalgia—Vemurafenib—melanoma	0.000472	0.00577	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.000468	0.00573	CcSEcCtD
Lovastatin—Anaphylactic shock—Vemurafenib—melanoma	0.000452	0.00554	CcSEcCtD
Lovastatin—Infection—Vemurafenib—melanoma	0.000449	0.0055	CcSEcCtD
Lovastatin—HMGCR—mammalian vulva—melanoma	0.000448	0.0245	CbGeAlD
Lovastatin—Phosphatase alkaline increased—Docetaxel—melanoma	0.000431	0.00527	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Temozolomide—melanoma	0.000423	0.00518	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000412	0.00504	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000397	0.00486	CcSEcCtD
Lovastatin—Decreased appetite—Vemurafenib—melanoma	0.000393	0.00481	CcSEcCtD
Lovastatin—Fatigue—Vemurafenib—melanoma	0.00039	0.00477	CcSEcCtD
Lovastatin—Constipation—Vemurafenib—melanoma	0.000387	0.00473	CcSEcCtD
Lovastatin—Erectile dysfunction—Temozolomide—melanoma	0.000374	0.00458	CcSEcCtD
Lovastatin—Photosensitivity reaction—Temozolomide—melanoma	0.000371	0.00454	CcSEcCtD
Lovastatin—Neuropathy peripheral—Carmustine—melanoma	0.000368	0.0045	CcSEcCtD
Lovastatin—Urinary tract infection—Carmustine—melanoma	0.000365	0.00446	CcSEcCtD
Lovastatin—Hepatitis—Dactinomycin—melanoma	0.00036	0.0044	CcSEcCtD
Lovastatin—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.00036	0.0044	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000359	0.0044	CcSEcCtD
Lovastatin—Flushing—Bleomycin—melanoma	0.000358	0.00438	CcSEcCtD
Lovastatin—Body temperature increased—Vemurafenib—melanoma	0.000358	0.00438	CcSEcCtD
Lovastatin—Neuropathy peripheral—Temozolomide—melanoma	0.000355	0.00435	CcSEcCtD
Lovastatin—HDAC2—head—melanoma	0.000355	0.0194	CbGeAlD
Lovastatin—Urinary tract infection—Temozolomide—melanoma	0.000352	0.00431	CcSEcCtD
Lovastatin—Hepatic failure—Docetaxel—melanoma	0.000348	0.00426	CcSEcCtD
Lovastatin—Chills—Bleomycin—melanoma	0.000346	0.00424	CcSEcCtD
Lovastatin—Alopecia—Bleomycin—melanoma	0.000341	0.00417	CcSEcCtD
Lovastatin—Erythema multiforme—Dactinomycin—melanoma	0.00034	0.00416	CcSEcCtD
Lovastatin—Sinusitis—Temozolomide—melanoma	0.00034	0.00416	CcSEcCtD
Lovastatin—Flushing—Dactinomycin—melanoma	0.000334	0.00409	CcSEcCtD
Lovastatin—Hypersensitivity—Vemurafenib—melanoma	0.000333	0.00408	CcSEcCtD
Lovastatin—Hepatitis—Temozolomide—melanoma	0.000325	0.00398	CcSEcCtD
Lovastatin—Asthenia—Vemurafenib—melanoma	0.000325	0.00397	CcSEcCtD
Lovastatin—Chills—Dactinomycin—melanoma	0.000323	0.00395	CcSEcCtD
Lovastatin—HMGCR—head—melanoma	0.00032	0.0175	CbGeAlD
Lovastatin—Pruritus—Vemurafenib—melanoma	0.00032	0.00392	CcSEcCtD
Lovastatin—Alopecia—Dactinomycin—melanoma	0.000318	0.00389	CcSEcCtD
Lovastatin—Pain in extremity—Docetaxel—melanoma	0.000313	0.00383	CcSEcCtD
Lovastatin—Flushing—Carmustine—melanoma	0.000312	0.00382	CcSEcCtD
Lovastatin—Ill-defined disorder—Bleomycin—melanoma	0.000312	0.00381	CcSEcCtD
Lovastatin—Diarrhoea—Vemurafenib—melanoma	0.000309	0.00379	CcSEcCtD
Lovastatin—Erythema multiforme—Temozolomide—melanoma	0.000308	0.00377	CcSEcCtD
Lovastatin—Malaise—Bleomycin—melanoma	0.000303	0.00371	CcSEcCtD
Lovastatin—Flushing—Temozolomide—melanoma	0.000302	0.0037	CcSEcCtD
Lovastatin—Leukopenia—Bleomycin—melanoma	0.000301	0.00368	CcSEcCtD
Lovastatin—Dizziness—Vemurafenib—melanoma	0.000299	0.00366	CcSEcCtD
Lovastatin—Alopecia—Carmustine—melanoma	0.000298	0.00364	CcSEcCtD
Lovastatin—Simvastatin—ABCB1—melanoma	0.000294	0.505	CrCbGaD
Lovastatin—Chills—Temozolomide—melanoma	0.000292	0.00357	CcSEcCtD
Lovastatin—Ill-defined disorder—Dactinomycin—melanoma	0.000291	0.00356	CcSEcCtD
Lovastatin—Pravastatin—ABCB1—melanoma	0.000288	0.495	CrCbGaD
Lovastatin—Vomiting—Vemurafenib—melanoma	0.000288	0.00352	CcSEcCtD
Lovastatin—Alopecia—Temozolomide—melanoma	0.000287	0.00352	CcSEcCtD
Lovastatin—Myalgia—Bleomycin—melanoma	0.000286	0.0035	CcSEcCtD
Lovastatin—Chest pain—Bleomycin—melanoma	0.000286	0.0035	CcSEcCtD
Lovastatin—Rash—Vemurafenib—melanoma	0.000285	0.00349	CcSEcCtD
Lovastatin—Dermatitis—Vemurafenib—melanoma	0.000285	0.00349	CcSEcCtD
Lovastatin—Back pain—Carmustine—melanoma	0.000283	0.00347	CcSEcCtD
Lovastatin—Headache—Vemurafenib—melanoma	0.000283	0.00347	CcSEcCtD
Lovastatin—Discomfort—Bleomycin—melanoma	0.000282	0.00346	CcSEcCtD
Lovastatin—Malaise—Dactinomycin—melanoma	0.000282	0.00346	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000282	0.00345	CcSEcCtD
Lovastatin—Cramp muscle—Docetaxel—melanoma	0.000282	0.00345	CcSEcCtD
Lovastatin—Leukopenia—Dactinomycin—melanoma	0.00028	0.00343	CcSEcCtD
Lovastatin—Dysgeusia—Temozolomide—melanoma	0.000277	0.00339	CcSEcCtD
Lovastatin—ABCB1—blood vessel—melanoma	0.000277	0.0152	CbGeAlD
Lovastatin—Confusional state—Bleomycin—melanoma	0.000276	0.00338	CcSEcCtD
Lovastatin—Vision blurred—Carmustine—melanoma	0.000276	0.00338	CcSEcCtD
Lovastatin—Tremor—Carmustine—melanoma	0.000275	0.00336	CcSEcCtD
Lovastatin—Anaphylactic shock—Bleomycin—melanoma	0.000274	0.00335	CcSEcCtD
Lovastatin—Back pain—Temozolomide—melanoma	0.000274	0.00335	CcSEcCtD
Lovastatin—Infection—Bleomycin—melanoma	0.000272	0.00333	CcSEcCtD
Lovastatin—Nausea—Vemurafenib—melanoma	0.000269	0.00329	CcSEcCtD
Lovastatin—Thrombocytopenia—Bleomycin—melanoma	0.000268	0.00328	CcSEcCtD
Lovastatin—Vision blurred—Temozolomide—melanoma	0.000267	0.00327	CcSEcCtD
Lovastatin—Myalgia—Dactinomycin—melanoma	0.000267	0.00326	CcSEcCtD
Lovastatin—Tremor—Temozolomide—melanoma	0.000265	0.00325	CcSEcCtD
Lovastatin—Discomfort—Dactinomycin—melanoma	0.000263	0.00322	CcSEcCtD
Lovastatin—Ill-defined disorder—Temozolomide—melanoma	0.000263	0.00322	CcSEcCtD
Lovastatin—Leukopenia—Carmustine—melanoma	0.000262	0.00321	CcSEcCtD
Lovastatin—Anorexia—Bleomycin—melanoma	0.000261	0.0032	CcSEcCtD
Lovastatin—Angioedema—Temozolomide—melanoma	0.000259	0.00317	CcSEcCtD
Lovastatin—Malaise—Temozolomide—melanoma	0.000255	0.00313	CcSEcCtD
Lovastatin—Vertigo—Temozolomide—melanoma	0.000254	0.00311	CcSEcCtD
Lovastatin—Infection—Dactinomycin—melanoma	0.000254	0.00311	CcSEcCtD
Lovastatin—Leukopenia—Temozolomide—melanoma	0.000254	0.0031	CcSEcCtD
Lovastatin—Thrombocytopenia—Dactinomycin—melanoma	0.00025	0.00306	CcSEcCtD
Lovastatin—SLCO1A2—head—melanoma	0.00025	0.0137	CbGeAlD
Lovastatin—Musculoskeletal discomfort—Bleomycin—melanoma	0.00025	0.00306	CcSEcCtD
Lovastatin—Chest pain—Carmustine—melanoma	0.00025	0.00305	CcSEcCtD
Lovastatin—Myalgia—Carmustine—melanoma	0.00025	0.00305	CcSEcCtD
Lovastatin—HDAC2—lymph node—melanoma	0.000249	0.0136	CbGeAlD
Lovastatin—Anxiety—Carmustine—melanoma	0.000249	0.00304	CcSEcCtD
Lovastatin—Paraesthesia—Bleomycin—melanoma	0.000246	0.00301	CcSEcCtD
Lovastatin—Dyspnoea—Bleomycin—melanoma	0.000244	0.00299	CcSEcCtD
Lovastatin—Anorexia—Dactinomycin—melanoma	0.000244	0.00298	CcSEcCtD
Lovastatin—Confusional state—Carmustine—melanoma	0.000241	0.00295	CcSEcCtD
Lovastatin—Arthralgia—Temozolomide—melanoma	0.000241	0.00295	CcSEcCtD
Lovastatin—Myalgia—Temozolomide—melanoma	0.000241	0.00295	CcSEcCtD
Lovastatin—Anxiety—Temozolomide—melanoma	0.00024	0.00294	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000239	0.00292	CcSEcCtD
Lovastatin—Discomfort—Temozolomide—melanoma	0.000238	0.00292	CcSEcCtD
Lovastatin—Decreased appetite—Bleomycin—melanoma	0.000238	0.00292	CcSEcCtD
Lovastatin—Infection—Carmustine—melanoma	0.000238	0.00291	CcSEcCtD
Lovastatin—Neuropathy peripheral—Docetaxel—melanoma	0.000236	0.00289	CcSEcCtD
Lovastatin—Dry mouth—Temozolomide—melanoma	0.000236	0.00289	CcSEcCtD
Lovastatin—Pain—Bleomycin—melanoma	0.000234	0.00287	CcSEcCtD
Lovastatin—Thrombocytopenia—Carmustine—melanoma	0.000234	0.00287	CcSEcCtD
Lovastatin—Confusional state—Temozolomide—melanoma	0.000233	0.00285	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000233	0.00285	CcSEcCtD
Lovastatin—Anaphylactic shock—Temozolomide—melanoma	0.000231	0.00283	CcSEcCtD
Lovastatin—Infection—Temozolomide—melanoma	0.00023	0.00281	CcSEcCtD
Lovastatin—Anorexia—Carmustine—melanoma	0.000228	0.00279	CcSEcCtD
Lovastatin—Thrombocytopenia—Temozolomide—melanoma	0.000226	0.00277	CcSEcCtD
Lovastatin—Feeling abnormal—Bleomycin—melanoma	0.000226	0.00276	CcSEcCtD
Lovastatin—HMGCR—lymph node—melanoma	0.000224	0.0123	CbGeAlD
Lovastatin—Decreased appetite—Dactinomycin—melanoma	0.000222	0.00272	CcSEcCtD
Lovastatin—Fatigue—Dactinomycin—melanoma	0.00022	0.0027	CcSEcCtD
Lovastatin—Anorexia—Temozolomide—melanoma	0.00022	0.0027	CcSEcCtD
Lovastatin—Pain—Dactinomycin—melanoma	0.000219	0.00268	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Carmustine—melanoma	0.000218	0.00267	CcSEcCtD
Lovastatin—Urticaria—Bleomycin—melanoma	0.000218	0.00266	CcSEcCtD
Lovastatin—Body temperature increased—Bleomycin—melanoma	0.000217	0.00265	CcSEcCtD
Lovastatin—Hepatitis—Docetaxel—melanoma	0.000216	0.00265	CcSEcCtD
Lovastatin—Insomnia—Carmustine—melanoma	0.000216	0.00265	CcSEcCtD
Lovastatin—Paraesthesia—Carmustine—melanoma	0.000215	0.00263	CcSEcCtD
Lovastatin—Dyspnoea—Carmustine—melanoma	0.000213	0.00261	CcSEcCtD
Lovastatin—Feeling abnormal—Dactinomycin—melanoma	0.000211	0.00258	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Temozolomide—melanoma	0.000211	0.00258	CcSEcCtD
Lovastatin—Insomnia—Temozolomide—melanoma	0.000209	0.00256	CcSEcCtD
Lovastatin—Gastrointestinal pain—Dactinomycin—melanoma	0.000209	0.00256	CcSEcCtD
Lovastatin—Decreased appetite—Carmustine—melanoma	0.000208	0.00255	CcSEcCtD
Lovastatin—Paraesthesia—Temozolomide—melanoma	0.000208	0.00254	CcSEcCtD
Lovastatin—Dyspnoea—Temozolomide—melanoma	0.000206	0.00252	CcSEcCtD
Lovastatin—Erythema multiforme—Docetaxel—melanoma	0.000205	0.0025	CcSEcCtD
Lovastatin—Constipation—Carmustine—melanoma	0.000205	0.0025	CcSEcCtD
Lovastatin—Pain—Carmustine—melanoma	0.000205	0.0025	CcSEcCtD
Lovastatin—Dyspepsia—Temozolomide—melanoma	0.000203	0.00249	CcSEcCtD
Lovastatin—Abdominal pain—Dactinomycin—melanoma	0.000202	0.00247	CcSEcCtD
Lovastatin—Body temperature increased—Dactinomycin—melanoma	0.000202	0.00247	CcSEcCtD
Lovastatin—Hypersensitivity—Bleomycin—melanoma	0.000202	0.00247	CcSEcCtD
Lovastatin—Decreased appetite—Temozolomide—melanoma	0.000201	0.00246	CcSEcCtD
Lovastatin—Flushing—Docetaxel—melanoma	0.000201	0.00246	CcSEcCtD
Lovastatin—Fatigue—Temozolomide—melanoma	0.000199	0.00244	CcSEcCtD
Lovastatin—Pain—Temozolomide—melanoma	0.000198	0.00242	CcSEcCtD
Lovastatin—Constipation—Temozolomide—melanoma	0.000198	0.00242	CcSEcCtD
Lovastatin—Feeling abnormal—Carmustine—melanoma	0.000197	0.00241	CcSEcCtD
Lovastatin—Asthenia—Bleomycin—melanoma	0.000197	0.00241	CcSEcCtD
Lovastatin—Gastrointestinal pain—Carmustine—melanoma	0.000196	0.00239	CcSEcCtD
Lovastatin—Chills—Docetaxel—melanoma	0.000194	0.00238	CcSEcCtD
Lovastatin—Pruritus—Bleomycin—melanoma	0.000194	0.00237	CcSEcCtD
Lovastatin—Alopecia—Docetaxel—melanoma	0.000191	0.00234	CcSEcCtD
Lovastatin—Feeling abnormal—Temozolomide—melanoma	0.00019	0.00233	CcSEcCtD
Lovastatin—Body temperature increased—Carmustine—melanoma	0.000189	0.00231	CcSEcCtD
Lovastatin—Abdominal pain—Carmustine—melanoma	0.000189	0.00231	CcSEcCtD
Lovastatin—Gastrointestinal pain—Temozolomide—melanoma	0.000189	0.00231	CcSEcCtD
Lovastatin—Hypersensitivity—Dactinomycin—melanoma	0.000188	0.0023	CcSEcCtD
Lovastatin—Dysgeusia—Docetaxel—melanoma	0.000184	0.00226	CcSEcCtD
Lovastatin—Urticaria—Temozolomide—melanoma	0.000184	0.00225	CcSEcCtD
Lovastatin—Asthenia—Dactinomycin—melanoma	0.000183	0.00224	CcSEcCtD
Lovastatin—Body temperature increased—Temozolomide—melanoma	0.000183	0.00224	CcSEcCtD
Lovastatin—Abdominal pain—Temozolomide—melanoma	0.000183	0.00224	CcSEcCtD
Lovastatin—Back pain—Docetaxel—melanoma	0.000182	0.00223	CcSEcCtD
Lovastatin—Muscle spasms—Docetaxel—melanoma	0.000181	0.00222	CcSEcCtD
Lovastatin—Hypersensitivity—Carmustine—melanoma	0.000176	0.00216	CcSEcCtD
Lovastatin—Diarrhoea—Dactinomycin—melanoma	0.000175	0.00214	CcSEcCtD
Lovastatin—Vomiting—Bleomycin—melanoma	0.000174	0.00213	CcSEcCtD
Lovastatin—Rash—Bleomycin—melanoma	0.000173	0.00211	CcSEcCtD
Lovastatin—Dermatitis—Bleomycin—melanoma	0.000173	0.00211	CcSEcCtD
Lovastatin—Asthenia—Carmustine—melanoma	0.000172	0.0021	CcSEcCtD
Lovastatin—Hypersensitivity—Temozolomide—melanoma	0.00017	0.00208	CcSEcCtD
Lovastatin—Leukopenia—Docetaxel—melanoma	0.000169	0.00206	CcSEcCtD
Lovastatin—Asthenia—Temozolomide—melanoma	0.000166	0.00203	CcSEcCtD
Lovastatin—Diarrhoea—Carmustine—melanoma	0.000164	0.002	CcSEcCtD
Lovastatin—Pruritus—Temozolomide—melanoma	0.000164	0.002	CcSEcCtD
Lovastatin—ABCC2—lymph node—melanoma	0.000163	0.00891	CbGeAlD
Lovastatin—Nausea—Bleomycin—melanoma	0.000163	0.00199	CcSEcCtD
Lovastatin—Vomiting—Dactinomycin—melanoma	0.000162	0.00199	CcSEcCtD
Lovastatin—Rash—Dactinomycin—melanoma	0.000161	0.00197	CcSEcCtD
Lovastatin—Myalgia—Docetaxel—melanoma	0.00016	0.00196	CcSEcCtD
Lovastatin—Arthralgia—Docetaxel—melanoma	0.00016	0.00196	CcSEcCtD
Lovastatin—Chest pain—Docetaxel—melanoma	0.00016	0.00196	CcSEcCtD
Lovastatin—Dizziness—Carmustine—melanoma	0.000158	0.00194	CcSEcCtD
Lovastatin—Diarrhoea—Temozolomide—melanoma	0.000158	0.00194	CcSEcCtD
Lovastatin—Dry mouth—Docetaxel—melanoma	0.000157	0.00192	CcSEcCtD
Lovastatin—Confusional state—Docetaxel—melanoma	0.000155	0.0019	CcSEcCtD
Lovastatin—Anaphylactic shock—Docetaxel—melanoma	0.000154	0.00188	CcSEcCtD
Lovastatin—Dizziness—Temozolomide—melanoma	0.000153	0.00187	CcSEcCtD
Lovastatin—Infection—Docetaxel—melanoma	0.000153	0.00187	CcSEcCtD
Lovastatin—Vomiting—Carmustine—melanoma	0.000152	0.00186	CcSEcCtD
Lovastatin—Nausea—Dactinomycin—melanoma	0.000152	0.00186	CcSEcCtD
Lovastatin—Rash—Carmustine—melanoma	0.000151	0.00185	CcSEcCtD
Lovastatin—Dermatitis—Carmustine—melanoma	0.000151	0.00184	CcSEcCtD
Lovastatin—Thrombocytopenia—Docetaxel—melanoma	0.000151	0.00184	CcSEcCtD
Lovastatin—Headache—Carmustine—melanoma	0.00015	0.00183	CcSEcCtD
Lovastatin—Vomiting—Temozolomide—melanoma	0.000147	0.0018	CcSEcCtD
Lovastatin—Anorexia—Docetaxel—melanoma	0.000147	0.00179	CcSEcCtD
Lovastatin—ABCB1—retina—melanoma	0.000146	0.00799	CbGeAlD
Lovastatin—Rash—Temozolomide—melanoma	0.000146	0.00178	CcSEcCtD
Lovastatin—Dermatitis—Temozolomide—melanoma	0.000146	0.00178	CcSEcCtD
Lovastatin—Headache—Temozolomide—melanoma	0.000145	0.00177	CcSEcCtD
Lovastatin—Nausea—Carmustine—melanoma	0.000142	0.00174	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Docetaxel—melanoma	0.00014	0.00171	CcSEcCtD
Lovastatin—Insomnia—Docetaxel—melanoma	0.000139	0.0017	CcSEcCtD
Lovastatin—Paraesthesia—Docetaxel—melanoma	0.000138	0.00169	CcSEcCtD
Lovastatin—Nausea—Temozolomide—melanoma	0.000137	0.00168	CcSEcCtD
Lovastatin—Dyspnoea—Docetaxel—melanoma	0.000137	0.00168	CcSEcCtD
Lovastatin—Dyspepsia—Docetaxel—melanoma	0.000135	0.00166	CcSEcCtD
Lovastatin—Decreased appetite—Docetaxel—melanoma	0.000134	0.00164	CcSEcCtD
Lovastatin—Fatigue—Docetaxel—melanoma	0.000133	0.00162	CcSEcCtD
Lovastatin—Constipation—Docetaxel—melanoma	0.000131	0.00161	CcSEcCtD
Lovastatin—Pain—Docetaxel—melanoma	0.000131	0.00161	CcSEcCtD
Lovastatin—Feeling abnormal—Docetaxel—melanoma	0.000127	0.00155	CcSEcCtD
Lovastatin—Gastrointestinal pain—Docetaxel—melanoma	0.000126	0.00154	CcSEcCtD
Lovastatin—Abdominal pain—Docetaxel—melanoma	0.000122	0.00149	CcSEcCtD
Lovastatin—Body temperature increased—Docetaxel—melanoma	0.000122	0.00149	CcSEcCtD
Lovastatin—ABCB1—mammalian vulva—melanoma	0.000117	0.0064	CbGeAlD
Lovastatin—CYP2D6—head—melanoma	0.000116	0.00636	CbGeAlD
Lovastatin—Hypersensitivity—Docetaxel—melanoma	0.000113	0.00139	CcSEcCtD
Lovastatin—Asthenia—Docetaxel—melanoma	0.00011	0.00135	CcSEcCtD
Lovastatin—Pruritus—Docetaxel—melanoma	0.000109	0.00133	CcSEcCtD
Lovastatin—Diarrhoea—Docetaxel—melanoma	0.000105	0.00129	CcSEcCtD
Lovastatin—Dizziness—Docetaxel—melanoma	0.000102	0.00124	CcSEcCtD
Lovastatin—Vomiting—Docetaxel—melanoma	9.77e-05	0.0012	CcSEcCtD
Lovastatin—Rash—Docetaxel—melanoma	9.69e-05	0.00119	CcSEcCtD
Lovastatin—Dermatitis—Docetaxel—melanoma	9.68e-05	0.00119	CcSEcCtD
Lovastatin—Headache—Docetaxel—melanoma	9.63e-05	0.00118	CcSEcCtD
Lovastatin—Nausea—Docetaxel—melanoma	9.13e-05	0.00112	CcSEcCtD
Lovastatin—ABCB1—head—melanoma	8.37e-05	0.00458	CbGeAlD
Lovastatin—ABCB1—lymph node—melanoma	5.86e-05	0.0032	CbGeAlD
Lovastatin—CYP2C8—Metabolism—CYP17A1—melanoma	5.21e-06	4.13e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MAP2K1—melanoma	5.2e-06	4.12e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PIK3CD—melanoma	5.16e-06	4.09e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.14e-06	4.08e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PPARG—melanoma	5.12e-06	4.06e-05	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—MAPK3—melanoma	5.11e-06	4.05e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	5.08e-06	4.03e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—VCAN—melanoma	5.07e-06	4.02e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CYP1B1—melanoma	5.07e-06	4.02e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	5.04e-06	4e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—VCAN—melanoma	5.03e-06	3.99e-05	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—MYC—melanoma	4.97e-06	3.94e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—STAT3—melanoma	4.96e-06	3.94e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—NRAS—melanoma	4.95e-06	3.93e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CG—melanoma	4.95e-06	3.92e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FGF2—melanoma	4.94e-06	3.92e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GNA11—melanoma	4.92e-06	3.9e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PHGDH—melanoma	4.82e-06	3.83e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—LUM—melanoma	4.82e-06	3.83e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—FASN—melanoma	4.82e-06	3.82e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PPARG—melanoma	4.77e-06	3.79e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	4.76e-06	3.78e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.75e-06	3.77e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MAPK3—melanoma	4.74e-06	3.76e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PTEN—melanoma	4.74e-06	3.76e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—SLC5A5—melanoma	4.74e-06	3.76e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—HPSE—melanoma	4.73e-06	3.75e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PIK3CB—melanoma	4.66e-06	3.7e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PIK3CD—melanoma	4.66e-06	3.7e-05	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	4.66e-06	3.69e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CYP17A1—melanoma	4.65e-06	3.69e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CUBN—melanoma	4.64e-06	3.68e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MDM2—melanoma	4.62e-06	3.67e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PTGS2—melanoma	4.62e-06	3.67e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MYC—melanoma	4.61e-06	3.66e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ALB—melanoma	4.6e-06	3.65e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.59e-06	3.64e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.59e-06	3.64e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GNAQ—melanoma	4.58e-06	3.63e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CD44—melanoma	4.58e-06	3.63e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ERBB2—melanoma	4.56e-06	3.62e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP17A1—melanoma	4.54e-06	3.6e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CG—melanoma	4.53e-06	3.6e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	4.53e-06	3.59e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MAPK1—melanoma	4.51e-06	3.58e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—EGFR—melanoma	4.51e-06	3.58e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PIK3CB—melanoma	4.5e-06	3.57e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SDHD—melanoma	4.48e-06	3.56e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CSPG4—melanoma	4.48e-06	3.56e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—BSG—melanoma	4.48e-06	3.56e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.48e-06	3.55e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.44e-06	3.52e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GNA11—melanoma	4.39e-06	3.49e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CYP1B1—melanoma	4.39e-06	3.48e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PPARG—melanoma	4.37e-06	3.47e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CD—melanoma	4.35e-06	3.45e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GPAM—melanoma	4.34e-06	3.44e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CXCL8—melanoma	4.32e-06	3.43e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—FASN—melanoma	4.3e-06	3.41e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ALB—melanoma	4.29e-06	3.4e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GNA11—melanoma	4.29e-06	3.4e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP17A1—melanoma	4.28e-06	3.39e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—KRAS—melanoma	4.26e-06	3.38e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP17A1—melanoma	4.24e-06	3.37e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—SLC5A5—melanoma	4.23e-06	3.36e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CDKN1B—melanoma	4.22e-06	3.35e-05	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	4.2e-06	3.33e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—FASN—melanoma	4.2e-06	3.33e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.18e-06	3.32e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ABCB1—melanoma	4.17e-06	3.31e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CG—melanoma	4.16e-06	3.3e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CASP3—melanoma	4.14e-06	3.28e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL2—melanoma	4.13e-06	3.28e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	4.13e-06	3.28e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—SLC5A5—melanoma	4.13e-06	3.27e-05	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PIK3CA—melanoma	4.1e-06	3.25e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GNAQ—melanoma	4.09e-06	3.24e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CD44—melanoma	4.09e-06	3.24e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PIK3CB—melanoma	4.06e-06	3.22e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GNA11—melanoma	4.04e-06	3.21e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PTEN—melanoma	4.03e-06	3.2e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCND1—melanoma	4.03e-06	3.19e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTGS2—melanoma	4.02e-06	3.19e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PPARG—melanoma	4.02e-06	3.18e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GNA11—melanoma	4.01e-06	3.18e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4e-06	3.17e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CTNNB1—melanoma	3.99e-06	3.16e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CD44—melanoma	3.99e-06	3.16e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GNAQ—melanoma	3.99e-06	3.16e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CD—melanoma	3.98e-06	3.16e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.96e-06	3.14e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—FASN—melanoma	3.96e-06	3.14e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ALB—melanoma	3.93e-06	3.12e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—FASN—melanoma	3.92e-06	3.11e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CYP1B1—melanoma	3.92e-06	3.11e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PIK3CA—melanoma	3.92e-06	3.11e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MMP9—melanoma	3.91e-06	3.1e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CDKN1A—melanoma	3.9e-06	3.09e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SLC5A5—melanoma	3.89e-06	3.09e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PTEN—melanoma	3.89e-06	3.08e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.87e-06	3.07e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NFKB1—melanoma	3.87e-06	3.07e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SLC5A5—melanoma	3.86e-06	3.06e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PRKCA—melanoma	3.84e-06	3.05e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP1B1—melanoma	3.82e-06	3.03e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ERCC2—melanoma	3.81e-06	3.02e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CB—melanoma	3.79e-06	3.01e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CD44—melanoma	3.76e-06	2.98e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GNAQ—melanoma	3.76e-06	2.98e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTGS2—melanoma	3.76e-06	2.98e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GNAQ—melanoma	3.72e-06	2.95e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CD44—melanoma	3.72e-06	2.95e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PLA2G6—melanoma	3.69e-06	2.93e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CD—melanoma	3.66e-06	2.9e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.65e-06	2.89e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—HRAS—melanoma	3.62e-06	2.87e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.61e-06	2.87e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ABCB1—melanoma	3.61e-06	2.87e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ALB—melanoma	3.61e-06	2.86e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP1B1—melanoma	3.6e-06	2.86e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP1B1—melanoma	3.57e-06	2.83e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—VEGFA—melanoma	3.51e-06	2.78e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTEN—melanoma	3.51e-06	2.78e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—STAT3—melanoma	3.48e-06	2.76e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CB—melanoma	3.47e-06	2.75e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NRAS—melanoma	3.47e-06	2.75e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—IL6—melanoma	3.47e-06	2.75e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.46e-06	2.74e-05	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—AKT1—melanoma	3.45e-06	2.73e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTGS2—melanoma	3.44e-06	2.73e-05	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—AKT1—melanoma	3.35e-06	2.66e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PIK3CA—melanoma	3.34e-06	2.65e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PRKCA—melanoma	3.33e-06	2.64e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MAPK3—melanoma	3.32e-06	2.63e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—VCAN—melanoma	3.32e-06	2.63e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ERCC2—melanoma	3.3e-06	2.62e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTEN—melanoma	3.28e-06	2.6e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MYC—melanoma	3.23e-06	2.56e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ABCB1—melanoma	3.23e-06	2.56e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—AKT1—melanoma	3.2e-06	2.54e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CB—melanoma	3.19e-06	2.53e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MAPK1—melanoma	3.16e-06	2.51e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—EGFR—melanoma	3.16e-06	2.51e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTGS2—melanoma	3.16e-06	2.51e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.15e-06	2.5e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CG—melanoma	3.01e-06	2.39e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTEN—melanoma	3e-06	2.38e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—KRAS—melanoma	2.98e-06	2.37e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PRKCA—melanoma	2.97e-06	2.35e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ABCB1—melanoma	2.97e-06	2.35e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ERCC2—melanoma	2.94e-06	2.33e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ABCB1—melanoma	2.94e-06	2.33e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PPARG—melanoma	2.9e-06	2.3e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PRKCA—melanoma	2.9e-06	2.3e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ERCC2—melanoma	2.87e-06	2.28e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PIK3CA—melanoma	2.84e-06	2.26e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP17A1—melanoma	2.8e-06	2.22e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTEN—melanoma	2.75e-06	2.18e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PIK3CA—melanoma	2.74e-06	2.18e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.73e-06	2.17e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—AKT1—melanoma	2.73e-06	2.17e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PRKCA—melanoma	2.73e-06	2.17e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ERCC2—melanoma	2.71e-06	2.15e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PRKCA—melanoma	2.71e-06	2.15e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ERCC2—melanoma	2.68e-06	2.13e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TP53—melanoma	2.65e-06	2.1e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CD—melanoma	2.64e-06	2.1e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GNA11—melanoma	2.64e-06	2.1e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ALB—melanoma	2.61e-06	2.07e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CG—melanoma	2.6e-06	2.07e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—FASN—melanoma	2.59e-06	2.05e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SLC5A5—melanoma	2.54e-06	2.02e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—HRAS—melanoma	2.54e-06	2.01e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PPARG—melanoma	2.51e-06	1.99e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PIK3CA—melanoma	2.48e-06	1.96e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GNAQ—melanoma	2.46e-06	1.95e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CD44—melanoma	2.46e-06	1.95e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.44e-06	1.93e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL6—melanoma	2.43e-06	1.93e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP1B1—melanoma	2.36e-06	1.87e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CG—melanoma	2.32e-06	1.84e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—AKT1—melanoma	2.32e-06	1.84e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CA—melanoma	2.31e-06	1.83e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CB—melanoma	2.3e-06	1.83e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CD—melanoma	2.29e-06	1.82e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTGS2—melanoma	2.28e-06	1.81e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CG—melanoma	2.27e-06	1.8e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ALB—melanoma	2.26e-06	1.79e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PPARG—melanoma	2.24e-06	1.78e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AKT1—melanoma	2.24e-06	1.78e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.22e-06	1.76e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PPARG—melanoma	2.19e-06	1.74e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CG—melanoma	2.14e-06	1.7e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CG—melanoma	2.12e-06	1.68e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CA—melanoma	2.12e-06	1.68e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PPARG—melanoma	2.06e-06	1.64e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PPARG—melanoma	2.05e-06	1.62e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CD—melanoma	2.04e-06	1.62e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—AKT1—melanoma	2.02e-06	1.6e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ALB—melanoma	2.02e-06	1.6e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CB—melanoma	2e-06	1.58e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CD—melanoma	1.99e-06	1.58e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTEN—melanoma	1.99e-06	1.58e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTGS2—melanoma	1.98e-06	1.57e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ALB—melanoma	1.97e-06	1.56e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CA—melanoma	1.94e-06	1.54e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ABCB1—melanoma	1.94e-06	1.54e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—AKT1—melanoma	1.89e-06	1.5e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CD—melanoma	1.88e-06	1.49e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CD—melanoma	1.86e-06	1.48e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ALB—melanoma	1.86e-06	1.47e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ALB—melanoma	1.84e-06	1.46e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PRKCA—melanoma	1.78e-06	1.42e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CB—melanoma	1.78e-06	1.41e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ERCC2—melanoma	1.77e-06	1.4e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTGS2—melanoma	1.77e-06	1.4e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CB—melanoma	1.74e-06	1.38e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—AKT1—melanoma	1.73e-06	1.37e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTEN—melanoma	1.72e-06	1.37e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTGS2—melanoma	1.72e-06	1.37e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CB—melanoma	1.64e-06	1.3e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CB—melanoma	1.62e-06	1.29e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTGS2—melanoma	1.62e-06	1.29e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTGS2—melanoma	1.61e-06	1.28e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AKT1—melanoma	1.59e-06	1.26e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTEN—melanoma	1.54e-06	1.22e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTEN—melanoma	1.5e-06	1.19e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTEN—melanoma	1.42e-06	1.12e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CA—melanoma	1.4e-06	1.11e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTEN—melanoma	1.4e-06	1.11e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CG—melanoma	1.4e-06	1.11e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PPARG—melanoma	1.35e-06	1.07e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CD—melanoma	1.23e-06	9.75e-06	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CA—melanoma	1.22e-06	9.65e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALB—melanoma	1.21e-06	9.62e-06	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AKT1—melanoma	1.15e-06	9.1e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CA—melanoma	1.09e-06	8.61e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CB—melanoma	1.07e-06	8.5e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTGS2—melanoma	1.06e-06	8.42e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CA—melanoma	1.06e-06	8.41e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CA—melanoma	9.99e-07	7.92e-06	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AKT1—melanoma	9.94e-07	7.88e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CA—melanoma	9.9e-07	7.85e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTEN—melanoma	9.26e-07	7.34e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AKT1—melanoma	8.87e-07	7.04e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AKT1—melanoma	8.66e-07	6.87e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AKT1—melanoma	8.16e-07	6.47e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AKT1—melanoma	8.09e-07	6.42e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CA—melanoma	6.53e-07	5.18e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AKT1—melanoma	5.33e-07	4.23e-06	CbGpPWpGaD
